The number of magnetic resonance imaging (MRI) procedures has grown at an average of 10 percent annually over the last 10 years, and there are no signs of stopping as continuous advancements in MR have generated more precise diagnosis for brain and cardiac imaging, bringing it to the forefront of cutting-edge imaging technology.

Early in 2005, The Women’s Center for Radiology, in Orlando, FL, shut down their screen-film mammography systems and switched over to an entirely digital screening environment. They replaced their six analog systems with four Selenia digital mammography systems from Hologic. “We had been a beta site for another manufacturer,” said founder and medical director Susan Curry, M.D. “We knew that digital was the way we needed to go, and Hologic was far and away the superior technology.”


The “one-size-fits-all” approach to the radiology workstation no longer suits the radiologists’ needs. While vendors are racing to add more features and devices designed to raise the level of the radiologists’ performance, solutions lag behind in a field where technology is constantly evolving.


The breast imaging market has been reinvigorated with an expanding arsenal of diagnostic and screening technologies for breast cancer. The recent FDA clearance of Fuji’s FCRm system, the anticipated arrival of new CR systems for mammography, not to mention GE’s newcomer — MR spectroscopy for breast — are positioned to fill the void left by FFDM and redefine breast imaging.
DMIST Sparks Trend in FFDM

As scientists focus on eradicating cancer, heart and neurological disorders, innovations in medical imaging and IT are bringing us closer to prevention, treatments and cures for these deadly diseases.

Taking a MRI-guided breast biopsy in real time is a recent development and an important advancement in diagnosing breast cancer today. And while ITN recognizes our readers’ interest in timely applications for patients currently suffering from disease, on occasion, we look ahead to gain some perspective on the here and now.


What is Ziehm’s mission in the U.S. market?
Ströbel: In imaging, with our competitors, we are a little bit smaller in size. We are a technology-driven company, so that means we try to be innovative, and we deliver new products and new solutions in a short rate. What we need for that is market perceptiveness. Many people come here to learn about the latest medical advancements. We are able to identify trends and convert them within our innovative engineering company so that we have new products ready to go.

Dr. Katsumi Nakamura of Tobata Kyoritsu Hospital in Japan received first place honors at the 14th annual International Society for Magnetic Resonance in Medicine (ISMRM) meetings for research in non-contrast MRA imaging. Nakamura received the honors for his presentation comparing non-contrast fresh blood imaging (FBI) to 16-slice CT for the diagnosis of peripheral vascular disease using Toshiba’s 1.5 Tesla MRI system.

The Regional Shared Health Information Program (RSHIP), Alberta, Canada, has ordered dozens of Kodak CR and DR systems for installation in 34 hospitals and healthcare centers.
The David Thompson Health and East Central Health Regions ordered 43 Kodak Directview CR systems, one Directview DR 3000 System, six laser imaging systems, six film digitizers and a Kodak Directview Capture Link Systems, designed for cassette identification, scanning and image review functions on any networked Kodak CR systems.

Clinicians at the Virginia Commonwealth University Massey Cancer Center use new image-guided radiosurgery (IGRS) technology to control the spread of metastatic cancer.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now